Kiniksa Pharmaceuticals L... (KNSA)
undefined
undefined%
At close: undefined
20.20
-0.30%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income 14.08M 183.36M -157.92M -161.38M -161.87M -103.23M -64.87M -23.97M
Depreciation & Amortization 2.34M 2.40M 2.35M 2.40M 2.07M 286.00K 28.00K 22.00K
Stock-Based Compensation 27.15M 25.12M 25.17M 20.88M 15.08M 5.70M 897.00K 368.00K
Other Working Capital 11.48M -2.01M 6.91M 654.00K -12.32M 9.51M 12.92M 1.64M
Other Non-Cash Items 2.17M 2.99M 3.40M 1.52M 6.53M -1.12M -53.00K 293.00K
Deferred Income Tax -33.79M -185.50M 11.00K 4.36M -3.16M -978.00K -197.00K -46.00K
Change in Working Capital 1.35M -22.57M 689.00K -4.32M -17.02M 18.33M 13.93M 1.76M
Operating Cash Flow 13.30M 5.81M -126.30M -136.53M -158.37M -81.01M -50.22M -21.87M
Capital Expenditures -130.00K -105.00K -20.41M -283.00K -3.20M -5.29M -69.00K -3.00K
Acquisitions - 91.00K 20.00M 23.16M -52.42M - - -
Purchase of Investments -204.93M -135.86M -157.25M -430.21M -488.77M -402.01M - -
Sales Maturities Of Investments 175.51M 127.80M 306.30M 407.05M 541.19M 168.10M - -
Other Investing Acitivies - -7.97M -20.00M -23.16M 52.42M -233.91M - -
Investing Cash Flow -29.56M -8.08M 128.63M -23.44M 49.21M -239.20M -69.00K -3.00K
Debt Repayment - - - - - - - -
Common Stock Repurchased -2.21M -901.00K 5.88M - - - - -
Dividend Paid - - - - - - - -
Other Financial Acitivies 3.70M 3.42M 5.88M -1.14M 1.00M 187.54M 39.87M 42.51M
Financial Cash Flow 1.50M 2.52M 5.88M 227.09M 84.11M 346.74M 39.87M 42.51M
Net Cash Flow -14.76M 245.00K 8.22M 67.11M -25.05M 26.53M -10.41M 20.64M
Free Cash Flow 13.17M 5.70M -146.71M -136.81M -161.57M -86.30M -50.29M -21.87M